IRF5 rs729302 — The Interferon Dampener: A Protective Haplotype Tag
Interferon Regulatory Factor 5 (IRF5) is a master transcription factor for type I interferon
production and proinflammatory cytokine secretion — a molecular switch that, when overactive,
drives the chronic immune activation underlying systemic lupus erythematosus, rheumatoid
arthritis, systemic sclerosis, and Sjögren syndrome. rs729302 sits approximately 9 kilobases
upstream of the IRF5 coding sequence in the 5' promoter region, where it serves as the key
tag SNP | A variant in linkage disequilibrium with the true causal variant; used to track
haplotypes when the causal site is unknown or difficult to genotype
for a cluster of protective haplotypes that dampen interferon output. While rs10488631 (already
documented separately) marks the 3' risk haplotype block that amplifies IRF5 activity, rs729302
marks an opposing 5' protective block — the other end of a molecular rheostat controlling how
loudly your immune system broadcasts the interferon alarm.
The Mechanism
The rs729302 variant is an A-to-C substitution in the 5' regulatory region of IRF5.
The common A allele is the reference (risk-direction) allele; the C allele is the minor
allele that tags the protective haplotypes. In luciferase reporter gene assays using
lymphoblastoid cells, the C allele showed borderline increased transcriptional
activity and additional transcription factor binding relative to the A allele in
electrophoretic mobility shift assays | Fernández-Hernández et al. 2013, Arthritis
Research & Therapy; the functional difference was modest, suggesting rs729302 itself may
not be causal but rather tags a nearby causal regulatory element.
The protective haplotypes tagged by rs729302-C reside in the 5' side of the IRF5 locus
and are functionally distinct from — and independent of — the three-block risk haplotype
system anchored by rs2004640, the exon 6 INDEL, and rs10488631. Conditional analysis in
the landmark 14-cohort European SLE study demonstrated that the protective signal from
rs729302 persisted after conditioning on all known susceptibility variants | Including
rs10488631, rs2004640, and the CGGGG promoter indel — indicating the protective signal
is not simply an absence of risk alleles,
establishing it as a genuinely independent protective locus within the gene. Subsequent work
in the comprehensive HMG haplotype study found that the rs729302 association signal is
partially explained by linkage disequilibrium with the CGGGG insertion-deletion
polymorphism | A 5-bp indel in the IRF5 promoter that creates or destroys an Sp1
transcription factor binding site, altering basal IRF5 transcription,
but the variant remains the best available tag SNP for this protective haplotype block on
current genotyping arrays.
The Evidence
The foundational evidence for rs729302 comes from the same landmark 14-cohort European
study that identified rs10488631 as the leading IRF5 susceptibility signal. Examining 1,383
SLE cases and 1,614 controls, Ferreiro-Neira et al. found that two SNPs at the IRF5
locus showed independent and opposed associations | Susceptibility: rs10488631, P<10⁻¹⁷;
protection: rs729302, P<10⁻⁶. The protective
signal from rs729302 was statistically independent of the susceptibility signal, meaning
individuals can carry both — their net interferon tone reflecting a balance between the two
haplotype blocks.
The protective direction is consistent across diseases and populations. In rheumatoid arthritis,
a meta-analysis of five case-control studies (6,582 RA cases and 5,375 controls) |
Han et al. 2009, Journal of Rheumatology
confirmed the C allele is protective (random-effects OR=0.889, 95% CI 0.803–0.977,
P=0.015). The same study found that allele frequencies differ meaningfully between cases
and controls — the C allele is enriched in the healthy population relative to disease
patients, a pattern seen across cohorts.
In Korean SLE patients, rs729302 showed the same directionality: the A allele was
enriched in cases (frequency 0.729) compared to controls (frequency 0.680), yielding
OR=1.27 (95% CI 1.08–1.49, P=0.0037) | Shin et al. 2007, Arthritis Research & Therapy; Korean
study mirroring European findings
for the risk A allele. In Japanese RA patients, the A allele showed OR=1.22 (P<0.001)
for disease susceptibility, with a particularly strong effect in HLA shared-epitope-negative
patients (OR=1.50), suggesting rs729302 captures a distinct autoimmune pathway | One
independent of the classical HLA shared epitope mechanism that dominates seropositive RA.
The C allele frequency in controls (approximately 32% in Europeans) versus cases
(approximately 27%) in the Swedish SLE cohort represents a meaningful enrichment of the
protective allele in the healthy population — quantitatively modest per allele, but
clinically meaningful across a locus with such broad autoimmune relevance.
Practical Implications
Carrying one or two copies of the C allele at rs729302 indicates your IRF5 locus carries
partial or full protective haplotype coverage in the 5' regulatory region. This does not
confer immunity to autoimmune disease — environmental triggers, other genetic variants
(including the 3' risk haplotype tagged by rs10488631), and stochastic immune events all
play important roles. However, the C allele is measurably associated with lower interferon
output and reduced disease susceptibility across multiple autoimmune conditions.
The most clinically relevant implication is in the context of the full IRF5 haplotype:
individuals who carry the rs729302-C protective allele alongside the rs10488631-T
(non-risk) allele have the lowest IRF5-mediated autoimmune risk, while those who carry
rs729302-A alongside rs10488631-C face the highest. The intermediate scenarios — carrying
protective alleles at one locus and risk alleles at the other — result in partially
offsetting effects on interferon tone.
Interactions
rs729302 operates in the same IRF5 locus as rs2004640 (exon 1B splice site, documented
separately) and rs10488631 (3' haplotype tag, documented separately). The three-block
haplotype structure of IRF5 means individuals carry combinations of haplotypes across all
three blocks simultaneously. The rs729302 protective haplotype is functionally and
statistically independent of the rs10488631 susceptibility haplotype — they can coexist
in the same genome, and the individual's net interferon phenotype reflects the sum of
contributions across all three blocks.
The IRF5 locus also interacts additively with STAT4 (rs7574865), which encodes the
signal transducer downstream of type I interferon. IRF5 drives interferon production;
STAT4 amplifies cellular responsiveness to that interferon. rs729302-C carriers who also
carry the STAT4 rs7574865 non-risk (CC) genotype have a double buffer — reduced
production and reduced responsiveness — giving the most protected interferon pathway
configuration.
All Genotypes
No IRF5 protective allele at this locus; standard autoimmune disease susceptibility
You carry two copies of the A allele at rs729302, meaning you do not carry the IRF5 protective haplotype at this 5' locus. Your type I interferon pathway regulation at this site is at population baseline — neither elevated by this variant nor buffered by the protective haplotype. This is the most common genotype globally, carried by approximately 45% of people. Among European populations, about 45% share this genotype. Your autoimmune disease risk at the IRF5 locus is determined by your genotype at the complementary susceptibility site (rs10488631) rather than by this protective variant.
One copy of the IRF5 protective haplotype tag, associated with modestly reduced autoimmune disease susceptibility
You carry one copy of the protective C allele at rs729302, meaning one of your two IRF5 gene copies runs on the protective haplotype in the 5' regulatory region. This is associated with modestly reduced susceptibility to lupus and rheumatoid arthritis compared to AA carriers. In European SLE cohorts, the C allele was enriched in healthy controls versus patients (allele frequencies approximately 34% vs 27%), and in RA meta-analysis the C allele carried an OR of 0.889 for protection. Approximately 44% of people carry one C allele at this site.
Two copies of the IRF5 protective haplotype tag, associated with meaningfully reduced autoimmune disease susceptibility
You carry two copies of the protective C allele at rs729302, meaning both copies of your IRF5 gene carry the protective haplotype at this 5' regulatory locus. This is associated with the lowest IRF5-mediated autoimmune disease susceptibility at this locus — you carry no copies of the A allele that tags the susceptibility-associated haplotype. In European SLE cohorts, C allele frequency was approximately 34% in healthy controls versus 27% in patients; homozygous CC individuals fall at the protected end of this distribution. Approximately 11% of people carry this genotype.